The use of 2-[18F]fluoro-2-deoxy-D-glucose as a potential in vitro agent for labelling human granulocytes for clinical studies by positron emission tomography.

Source:http://linkedlifedata.com/resource/pubmed/id/1601671

Download in:

View as

General Info

PMID
1601671